U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
162121162121MVA Post-Event: Administration Timing and Boost StudyCompletedNo Results AvailableSmallpoxDrug: Placebo (subcutaneous)|Drug: Placebo (scarification)|Biological: Dryvax®|Biological: IMVAMUNE®https://ClinicalTrials.gov/show/NCT00437021
162122162122Effects of Benfotiamine and AGE on Endothelial Function in People With DiabetesCompletedNo Results AvailableEndothelial Dysfunction|Type 2 Diabetes MellitusDrug: Benfotiamine 1050mg, 3 days|Behavioral: high-AGE vs. low-AGE mealhttps://ClinicalTrials.gov/show/NCT00437008
162123162123Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving DialysisCompletedNo Results AvailableChronic Kidney DiseaseDrug: Darbepoetin Alfahttps://ClinicalTrials.gov/show/NCT00436995
162124162124Evaluation of Triathlon - a New Total Knee Prosthesis SystemRecruitingNo Results AvailableTotal Knee ArthroplastyDevice: Triathlon Knee Systemhttps://ClinicalTrials.gov/show/NCT00436982
162125162125ORTHOVISC Shoulder RCTCompletedHas ResultsGlenohumeral OsteoarthritisDevice: Orthovisc|Drug: Control|Drug: Controlhttps://ClinicalTrials.gov/show/NCT00436969
162126162126AZD2171 to Treat Prostate CancerCompletedHas ResultsProstate CancerProcedure: Magnetic Resonance Imaging (DCE-MRI)|Drug: AZD2171|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00436956
162127162127Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient ClinicTerminatedNo Results AvailableSmokingDrug: nicotine replacement therapy and bupropion|Behavioral: smoking cessation counseling and referralshttps://ClinicalTrials.gov/show/NCT00436943
162128162128Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: autologous tumor cell vaccine|Biological: sargramostim|Biological: therapeutic autologous dendritic cellshttps://ClinicalTrials.gov/show/NCT00436930
162129162129Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast CancerActive, not recruitingHas ResultsBreast Cancer|OsteoporosisDrug: zoledronic acid|Procedure: Letrozole as adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00436917
162130162130Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic LeukemiaCompletedHas ResultsLeukemiaDrug: Alemtuzumab|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00436904
162131162131Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in FijiCompletedNo Results AvailableStreptococcus Group Ahttps://ClinicalTrials.gov/show/NCT00436891
162132162132Intake Promoting Effects of Large Portions in ChildrenRecruitingNo Results AvailableFood IntakeBehavioral: Food portion sizehttps://ClinicalTrials.gov/show/NCT00436878
162133162133Insulin and the Polycystic Ovary Syndrome--Weight Reduction StudyRecruitingNo Results AvailablePolycystic Ovary Syndrome|ObesityBehavioral: Weight losshttps://ClinicalTrials.gov/show/NCT00436865
162134162134ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous TreatmentActive, not recruitingHas ResultsDisseminated Neuroblastoma|Recurrent NeuroblastomaDrug: ABT-751|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00436852
162135162135Taxotere Prostate Cancer New Indication Registration Trial in ChinaCompletedNo Results AvailableProstatic NeoplasmsDrug: Docetaxel|Drug: Mitoxantrone|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00436839
162136162136A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)CompletedHas ResultsMultiple SclerosisDrug: Cladribine|Drug: Placebo|Drug: Interferon-beta (IFN-beta)https://ClinicalTrials.gov/show/NCT00436826
162137162137Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNo Results AvailableNasopharyngeal NeoplasmsDrug: Gemcitabine|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00436800
162138162138Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese VolunteersCompletedNo Results AvailableVenous Thrombosis|Pulmonary EmbolismDrug: Fondaparinux Sodiumhttps://ClinicalTrials.gov/show/NCT00436787
162139162139Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01RecruitingNo Results AvailableChildhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Gastrointestinal Complications|Infertility|Long-term Effects Secondary to Cancer Therapy in Children|Neurotoxicity|Ovarian Cancer|Pulmonary Complications|Sexual Dysfunction|Urinary ComplicationsProcedure: assessment of therapy complications|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00436774
162140162140Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid TumorsActive, not recruitingNo Results AvailableUnspecified Childhood Solid Tumor, Protocol SpecificBiological: anti-thymocyte globulin|Biological: graft-versus-tumor induction therapy|Biological: sargramostim|Drug: busulfan|Drug: cyclosporine|Drug: melphalan|Drug: methylprednisolone|Other: flow cytometry|Other: immunologic technique|Other: laboratory biomarker analysis|Procedure: allogeneic hematopoietic stem cell transplantation|Procedure: umbilical cord blood transplantationhttps://ClinicalTrials.gov/show/NCT00436761
162141162141Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney DiseaseTerminatedHas ResultsAnemia|Chronic Kidney Disease|Kidney DiseaseDrug: Darbepoetin Alfa|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00436748
162142162142Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid TumorsActive, not recruitingNo Results AvailableColorectal Cancer|Gastrointestinal Carcinoid Tumor|Head and Neck Cancer|Islet Cell Tumor|Lung Cancer|Metastatic Cancer|Neuroendocrine Carcinoma of the Skin|Ovarian Cancer|Pheochromocytoma|Sarcoma|Unspecified Adult Solid Tumor, Protocol SpecificDrug: midazolam hydrochloride|Drug: nelfinavir mesylate|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunoenzyme technique|Other: immunologic technique|Other: laboratory biomarker analysis|Other: mass spectrometryhttps://ClinicalTrials.gov/show/NCT00436735
162143162143Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative TrialTerminatedNo Results AvailableLiver DiseasesDrug: ATG (Fresenius Biotech)https://ClinicalTrials.gov/show/NCT00436722
162144162144Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerActive, not recruitingNo Results AvailableBreast CancerBiological: bevacizumab|Biological: pegfilgrastim|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel albumin-stabilized nanoparticle formulation|Other: flow cytometry|Other: immunoenzyme technique|Other: immunologic technique|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: immunoscintigraphyhttps://ClinicalTrials.gov/show/NCT00436709
162145162145Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous ConditionsActive, not recruitingNo Results AvailableNeuroblastomaGenetic: gene mapping|Genetic: polymorphism analysishttps://ClinicalTrials.gov/show/NCT00436696
162146162146Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With HyperphosphataemiaCompletedNo Results AvailableChronic Kidney FailureDrug: Fermagate|Drug: Sevelamer HClhttps://ClinicalTrials.gov/show/NCT00436683
162147162147Phase II Study to Evaluate the Efficacy of AMG 317CompletedNo Results AvailableAsthmaBiological: AMG 317 75 mg|Biological: AMG 317 150 mg|Biological: AMG 317 300 mg|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00436670
162148162148Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNo Results AvailablePeritoneal Neoplasms|Retroperitoneal Neoplasms|Gastrointestinal Neoplasms|Adenocarcinoma|Neuroblastoma|Ovarian Neoplasms|Sarcoma|Adrenocortical Carcinoma|Wilms Tumor|Rhabdomyosarcoma|Desmoplastic Small Round Cell TumorDrug: CHPP of Cisplatin|Procedure: Abdominal Surgeryhttps://ClinicalTrials.gov/show/NCT00436657
162149162149Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or CarboplatinCompletedHas ResultsOvarian Cancer|Peritoneal Cavity CancerDrug: Lapatinib|Drug: Topotecanhttps://ClinicalTrials.gov/show/NCT00436644
162150162150Internet Administration of the Modified Atkins Diet for Adults With Intractable EpilepsyCompletedNo Results AvailableEpilepsyBehavioral: Dietary management of seizureshttps://ClinicalTrials.gov/show/NCT00436631

* Görseller ve İçerik tekif hakkına sahip olabilir